In 2024, health insurance companies spent the largest amount of funds on the treatment of malignant tumors. For the first time, the expenses for the treatment of cancer patients, which amounted to 55.8 billion crowns, exceeded the expenses for the treatment of diseases of the circulatory system, which amounted to 54.2 billion crowns. (translated)




